Expansion & partnerships fuel record growth for BMS
Biomedical Structures LLC (BMS), a provider of biomedical textiles for medical devices and other advanced clinical applications, announced that it has achieved record growth in 2010 via several milestones that have marked the company's expansion this year.
In May, BMS completed a private equity financing with Ampersand Ventures, and has since moved forward with expanded services and equipment to satisfy the increasing demands of its medical device customers for improved manufacturing capacity and engineering expertise for a widening range of biomaterials.
Specifically, BMS added a new purpose-built clean room for high-density weaving and knitting, which now houses state-of-the-art warping and twisting equipment for precise biomedical textile solutions for orthopedic, cardiovascular, and general surgery device applications. The company has also improved its advanced braiding infrastructure for polymer and wire materials with multiple new braiding machines, as well as a best-in-class 48-carrier machine for enhanced production capacity.
"The Ampersand investment came at a critical time for BMS," said President John Gray. "We were experiencing a significant increase in the need for our biomedical textile manufacturing expertise, and aimed to use the investment to expand to meet this growth. And since then, we have done exactly as we planned, with expanded clean room facilities and equipment, new partners, and new hires to help meet the market demand for our services. 2010 has been a tremendous year for BMS, and we are eagerly looking forward to continuing this growth into 2011 and beyond."
Additional growth following the investment included a cooperative relationship with fiber manufacturer DSM Dyneema around its Dyneema Purity fiber. BMS is now a proven specialist in processing Dyneema Purity and recently-launched Dyneema Purity BLUE, the first ever 100% implantable grade Ultra High Molecular Weight Polyethylene (UHMWPE) fiber in the world. The company's new facility addition has been purpose-built for handling Dyneema Purity, as well as other fine mono- and multifilament fibers, and will enable BMS to further innovate on its biomedical textile development capabilities for orthopedic and cardiovascular device applications.
In a continuing effort to provide a robust resource for engineers looking for innovative solutions to their device challenges, BMS also unveiled its new company website in November. Live now at www.bmsri.com, the site is designed to provide a resource for product engineers and device manufacturers considering biomedical textiles for their next-generation applications in a wide range of clinical areas. A comprehensive overview of textile engineering techniques and properties for clinical applications, as well as regulatory resources, medical device industry links, and an extensive library of terms offer an informative destination for OEMs seeking to learn more.
BMS offers expertise in knitting, braiding, weaving, non-wovens, and composites, and utilizes implantable-grade absorbable and permanent fibers in orthopedic, general surgery, tissue engineering, cardiovascular, bariatric, cosmetic surgery, and veterinary applications, including implantable devices, drug delivery technologies, and surgical instrumentation.
Biomedical Structures LLC (BMS) specializes in the advanced design, development and manufacturing of biomedical textiles for device manufacturers in the orthopedic, cardiovascular, general surgery, and tissue engineering and regenerative medicine markets.
Biomedical Structures LLC